Verastem Stock Investor Sentiment
| VSTM Stock | USD 5.16 0.05 0.98% |
About 58% of all Verastem's investors are looking to take a long position. The analysis of the overall investor sentiment regarding Verastem suggests that some traders are interested. Verastem's investing sentiment overview a quick insight into current market opportunities from investing in Verastem. Many technical investors use Verastem stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Comfort Level 58
Interested
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Verastem's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Verastem.
News SentimentBullish | Hype SentimentNeutral | Insider SentimentDisposing |
Verastem Historical Sentiment
Although Verastem's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Verastem, such as negative comments on social media and news outlets, may cause fear in the market and push Verastem's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Verastem.
Verastem Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Verastem can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Verastem Historical Investor Sentiment
Investor biases related to Verastem's public news can be used to forecast risks associated with an investment in Verastem. The trend in average sentiment can be used to explain how an investor holding Verastem can time the market purely based on public headlines and social activities around Verastem. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Verastem's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Verastem and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Verastem news discussions. The higher the estimate score, the more favorable the investor's outlook on Verastem.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Verastem's Stock prices. Below is the latest headlines and news related to Verastem Stock. Current markets are slightly bullish. About 55% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Verastem that are available to investors today. This information is accessible both publicly - through Verastem's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Verastem-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Verastem news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Verastem relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Verastem's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Verastem alpha.
Verastem Largest EPS Surprises
Earnings surprises can significantly impact Verastem's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-05-09 | 2022-03-31 | -0.08 | -0.09 | -0.01 | 12 | ||
2023-03-14 | 2022-12-31 | -0.1 | -0.08 | 0.02 | 20 | ||
2021-08-02 | 2021-06-30 | -0.08 | -0.1 | -0.02 | 25 | ||
2022-11-03 | 2022-09-30 | -0.12 | -0.09 | 0.03 | 25 | ||
2016-11-07 | 2016-09-30 | -0.24 | -0.21 | 0.03 | 12 | ||
2021-03-18 | 2020-12-31 | -0.08 | -0.12 | -0.04 | 50 |
There is far too much social signal, news, headlines, and media speculation about Verastem that are available to investors today. This information is accessible both publicly - through Verastem's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Verastem-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Verastem news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Verastem relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Verastem's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Verastem alpha.
Verastem Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Verastem Oncology rises on 75M private placement | 04/25/2025 |
2 | Disposition of 820 shares by Paterson Dan of Verastem at 7.3 subject to Rule 16b-3 | 05/05/2025 |
3 | Verastem Non-GAAP EPS of -0.79 misses by 0.01 | 05/13/2025 |
4 | Disposition of 25000 shares by Paterson Dan of Verastem subject to Rule 16b-3 | 05/16/2025 |
5 | Verastem Oncology to Present at the Jefferies Global Healthcare Conference | 05/28/2025 |
6 | Disposition of 594 shares by Stuglik Brian M of Verastem at 5.65 subject to Rule 16b-3 | 06/16/2025 |
7 | Disposition of tradable shares by Daniel Calkins of Verastem at 4.71 subject to Rule 16b-3 | 06/23/2025 |
8 | Verastem Oncology Announces First Patient Dosed with VS-7375, an Oral KRAS G12D Inhibitor, in a U.S. Phase 12a Trial in KRAS G12D Advanced Solid Tumors | 06/24/2025 |
9 | Verastem Target Price Lowered by RBC Capital VSTM Stock News | 06/25/2025 |
10 | Dan Paterson Sells 17,808 Shares of Verastem, Inc. Stock | 06/26/2025 |
11 | Verastem, Inc. Receives Average Recommendation of Buy from Brokerages | 07/03/2025 |
12 | Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635 | 07/08/2025 |
13 | Verastem Oncology Announces Publication of the Primary Results from the Phase 2 RAMP 201 Trial ... | 07/11/2025 |
14 | Verastems avutometinib combination shows 31 percent ORR in ovarian cancer trial | 07/14/2025 |
Check out Verastem Hype Analysis, Verastem Correlation and Verastem Performance. To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verastem. If investors know Verastem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verastem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.36) | Revenue Per Share | Quarterly Revenue Growth (1.00) | Return On Assets | Return On Equity |
The market value of Verastem is measured differently than its book value, which is the value of Verastem that is recorded on the company's balance sheet. Investors also form their own opinion of Verastem's value that differs from its market value or its book value, called intrinsic value, which is Verastem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verastem's market value can be influenced by many factors that don't directly affect Verastem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verastem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verastem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verastem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.